Advertisement
A fan who wears his Cubs pride uniquely

A fan who wears his Cubs pride uniquely

By Modern Healthcare  |  October 15, 2016

True fans of a certain Chicago baseball team are said to bleed Cubbie blue. But Beckham Zobrist wears his loyalty upfront: The 7-year-old Cubs fan's prosthetic eye bears the team logo.

Innovations: Startup's liquid biopsies match cancer patients with trials

Innovations: Startup's liquid biopsies match cancer patients with trials

By Erica Teichert  |  August 20, 2016

Guardant Health, based in Redwood City, Calif., developed a liquid biopsy blood test that has helped match cancer patients with clinical trials and treatment options without costly or invasive biopsies. CEO and co-founder Helmy Eltoukhy calls it a “game changer” for oncology.

Doctors, insurers flock to Medicare's cancer payment demo despite questions

By Bob Herman  |  June 29, 2016

Seventeen private health insurance companies and more than 3,200 oncologists working in almost 200 medical groups will participate in the federal government's new cancer care project, but critics argue the program may not easily lower costs or reduce unnecessary and potentially harmful care.

Biden pushes cancer research data-sharing, threatens to pull funds from outliers

Biden pushes cancer research data-sharing, threatens to pull funds from outliers

By Shannon Muchmore  |  June 29, 2016

Vice President Joe Biden on Wednesday stressed the importance of research data-sharing and affordability in cancer treatments as goals for his Cancer Moonshot initiative. He also threatened to pull federal funding for cancer studies that fail to publicly disclose their results.

Blog: Biden says cancer 'moonshot' needs more teamwork

By Maria Castellucci  |  June 06, 2016

In an emotional speech, Vice President Joe Biden urged the 30,000 oncologists attending the American Society of Clinical Oncology's annual conference to work together in the search for a cure for cancer.

Cancer drugs cost more in U.S.

By Adam Rubenfire  |  June 06, 2016

It's well-known that Americans pay more for healthcare and drugs than many other nations, and a recent study confirms that the trend is the same when it comes to oncology drugs.

Breast cancer screening guidelines spark a racial divide

Breast cancer screening guidelines spark a racial divide

By Sabriya Rice and Steven Ross Johnson  |  May 07, 2016

Some health and civil-rights advocates say guidelines that recommend women postpone breast cancer screenings until they are age 50 should not apply to black women, who are more likely to die if they contract the disease.

Providers invest in next frontier of patient genetic data

Providers invest in next frontier of patient genetic data

By Beth Kutscher  |  May 07, 2016

As providers are tasked with keeping people healthy through risk-based payment contracts, they're investing in genomics and personalized medicine in order to develop new methods of targeting patients who need early intervention.

Q&A: American public's confidence in the FDA must be ensured

Q&A: American public's confidence in the FDA must be ensured

By Modern Healthcare  |  April 02, 2016

Dr. Robert Califf became commissioner of the FDA in February. He brings to the job more than 30 years of experience in clinical trial research at Duke University Medical Center. Califf discusses his priorities and some of the controversies that swirled around his nomination.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.